1. ALLA AKTIER
  2. NYHETER
  3. SENZAGEN

SenzaGen

Nyheter SenzaGen Nyheter alla bolag

SenzaGen’s 2022 Year-End Report: Breakthrough for SenzaGen in both sales and technology

MAR

Message from the CEO

“We closed our breakthrough year, 2022, on a very strong note with a 110% increase in sales for the second half year to SEK 21.8 million. Organic sales accounted for SEK 12.1 million, representing 70% organic growth. Late in the year, we saw strong demand for GARD® tests, which was largely driven by the OECD approval received earlier in the year. For the full year, total sales increased by as much as 171% to SEK 41.8 million. With our OECD-approved test, new innovative tests and a broader offering in a market that is continuing to grow from technological, regulatory and ethical drivers, I can see us in a very favorable position for continued high growth.”

Peter Nählstedt, President and CEO

Full year 1 January–31 December

  • Net sales totaled SEK 41.8 (15.4) million.
  • EBITDA amounted to SEK -15.7 (-27.3) million.
  • Earnings per share were SEK -1.03 (-1.35).
  • Cash and cash equivalents at 31 December amounted to SEK 40.0 (69.2) million.
  • The board proposes that no dividend be paid to the Company’s shareholders.

Second half year 1 July–31 December

  • Net sales totaled SEK 21.8 (10.4) million.
  • EBITDA amounted to SEK -6,6 (-15.5) million.
  • Earnings per share were SEK -0.47 (-0.78).

Significant events during the second half year

  • SenzaGen completed its largest test order to date for GARD®skin from a new customer, a world leader in chemicals, for a cumulative value of approximately SEK 1 million.
  • SenzaGen acquired ToxHub, an Italian company offering toxicology advisory services with specific expertise in medical devices and pharmacology.

Livestream presentation
SenzaGen is pleased to invite press and investors to a livestream presentation at 14:00 on February 16. The presentation will be given by SenzaGen’s President and CEO Peter Nählstedt, followed by a Q&A session moderated by Redeye's analyst Gustaf Meyer. The presentation will be held in English.

Time: Thursday February 16, 14:00–15:00 CET.
Link to the livestream: https://www.redeye.se/events/872235/live-q-senzagen-2

The presentation can be watched afterwards at SenzaGen’s website: https://senzagen.com/investors/presentations/

Contacts

Peter Nählstedt, President and CEO, SenzaGen AB
Email: peter.nahlstedt@senzagen.com | Mobile: +46 700 23 44 31

Tina Dackemark Lawesson, VP Marketing & Communications
Email: tina.lawesson@senzagen.com | Mobile: +46 708 20 29 44

About us

SenzaGen aims to be a leader in in vitro science and testing, driving the transition from animal testing to methods better suited to reflect human biology. The Company provides high-performance, non-animal test methods and innovation and consulting services based on state-of-the-art technology. Non-animal methods are more effective, more accurate and less expensive than traditional animal-based methods while also helping to reduce the number of laboratory animals. The Company has a growth strategy centered around continued commercialization of its proprietary GARD® test platform, expansion of its test portfolio and evaluation of acquisition opportunities of profitable and growing companies with complementary offerings. SenzaGen has its headquarters and GLP-certified laboratory in Lund, Sweden and subsidiaries in the US and Italy. For more information, please visit: www.senzagen.com.

SenzaGen is listed on Nasdaq Stockholm First North (ticker: SENZA). FNCA Sweden AB is the company’s Certified Adviser. 

This information is information that SenzaGen is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2023-02-16 08:30 CET.

Attachments

SenzaGen AB (publ) Year-End Report 2022

Datum 2023-02-16, kl 08:30
Källa MFN
Bifogade filer
SenzaGen AB (publ) Year-End Report 2022
Hej Serverägare! Har du problem med troll och spam? Nu finns möjligheten att sätta en liten avgift, t.ex. 20kr, på discord invites och därmed stoppa många återkommande troll samtidigt som du tjänar lite pengar. Kolla in Invite Paywall.